Evidence map›Paper›PMID 15504752›Full record

ArticleBritish journal of pharmacology2004

Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis.

Ying-Yuan Pamela Mok, Mohammed Shirhan Bin Mohammed Atan, Cheong Yoke Ping, Wang Zhong Jing, Madhav Bhatia, Shabbir Moochhala, Philip K Moore

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in British journal of pharmacology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01088490 (Hydrogen Sulfide as Prognostic Factor), which is not on this map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01088490 completednot on this mapstarted 2010, after this paper: background citation

Hydrogen Sulfide as Prognostic Factor

TypeobservationalSponsorUniversity Medical Centre LjubljanaRan2010 to 2014Enrolled50ConditionsMortality, Shock
3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 238 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Role of hydrogen sulfide in subarachnoid hemorrhage.CNS neuroscience & therapeutics · 2022
    Review
  13. Article
  14. Article
  15. HBiomolecules · 2021
    Review
  16. Review
  17. Article
  18. Review
  19. Hydrogen Sulfide and its Interaction with Other Players in Inflammation.Advances in experimental medicine and biology · 2021
    Article
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ying-Yuan Pamela MokDepartment of Pharmacology, National University of Singapore, Block MD2, 18 Medical Drive, 117597 Singapore.
Mohammed Shirhan Bin Mohammed Atan
Cheong Yoke Ping
Wang Zhong Jing
Madhav Bhatia
Shabbir Moochhala
Philip K Moore
National University of Singapore · SGDSO National Laboratories · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Haemorrhagic shock (60 min) in the anaesthetized rat resulted in a prolonged fall in the mean arterial blood pressure (MAP) and heart rate (HR). Pre-treatment (30 min before shock) or post-treatment (60 min after shock) with inhibitors of cystathionine gamma lyase (CSE; converts cysteine into hydrogen sulphide (H(2)S)), dl-propargylglycine or beta-cyanoalanine (50 mg kg(-1), i.v.), or glibenclamide (40 mg kg(-1), i.p.), produced a rapid, partial restoration in MAP and HR. Neither saline nor DMSO affected MAP or HR. Plasma H(2)S concentration was elevated 60 min after blood withdrawal (37.5+/-1.3 microM, n=18 c.f. 28.9+/-1.4 microM, n=15, P<0.05). The conversion of cysteine to H(2)S by liver (but not kidney) homogenates prepared from animals killed 60 min after withdrawal of blood was significantly increased (52.1+/-1.6 c.f. 39.8+/-4.1 nmol mg protein(-1), n=8, P<0.05), as was liver CSE mRNA (2.7 x). Both PAG (IC(50), 55.0+/-3.2 microM) and BCA (IC(50), 6.5+/-1.2 microM) inhibited liver H(2)S synthesizing activity in vitro. Pre-treatment of animals with PAG or BCA (50 mg kg(-1), i.p.) but not glibenclamide (40 mg kg(-1), i.p., K(ATP) channel inhibitor) abolished the rise in plasma H(2)S in animals exposed to 60 min haemorrhagic shock and prevented the augmented biosynthesis of H(2)S from cysteine in liver. These results demonstrate that H(2)S plays a role in haemorrhagic shock in the rat. CSE inhibitors may provide a novel approach to the treatment of haemorrhagic shock.

Indexed as

AlanineAlkynesAnimalsATP-Binding Cassette TransportersBlood PressureCystathionine gamma-LyaseCysteineEnzyme InhibitorsGlyburideGlycineHeart RateHydrogen SulfideHypoglycemic AgentsKATP ChannelsLiverMale3-cyanoalanineAlanineAlkynesATP-Binding Cassette TransportersCystathionine gamma-LyaseCysteineEnzyme InhibitorsGlyburideGlycineHydrogen SulfideHypoglycemic AgentsKATP ChannelsPotassium ChannelsPotassium Channels, Inwardly RectifyingpropargylglycineRNA, MessengeruK-ATP-1 potassium channel

Identifiers

PMID15504752
PMCPMC1575944
OpenAlexW2008664596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.